Comments on: Junshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa Region //dianhuaminglu.com/en/%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e4%b8%8ehikma%e5%b0%b1%e7%89%b9%e7%91%9e%e6%99%ae%e5%88%a9%e5%8d%95%e6%8a%97%e5%9c%a8%e4%b8%ad%e4%b8%9c%e5%92%8c%e5%8c%97%e9%9d%9e%e7%9a%84/ 创新疗法的发现、开发和商业化的生物制药公司?/description> Tue, 07 Mar 2023 07:33:40 +0000 hourly 1 //wordpress.org/?v=6.1.1